Chaired by Melanie Davies, this interactive IME webinar will focus on treatment with GLP-1RAs, based on real-world data, and the emerging landscape of GLP-1RAs in the context of approved guidelines.
People who are trying to maintain weight loss with the help of electronic health records-based tracking tools do significantly better if they are given access to an online coach, shows a randomized trial.
Islet autoantibody negativity plus mild hyperglycemia and a family history of diabetes can be used to identify children newly diagnosed with diabetes who should undergo genetic testing for maturity-onset diabetes of the young, study findings indicate.
A study of more than a thousand patients suggests that having both diabetic ketoacidosis and a hyperosmolar hyperglycemic state on arrival at hospital leads to more than twice the likelihood of death there than either condition alone.
Neither vitamin D nor omega-3 fatty acids are able to slow the decline in kidney function for people with type 2 diabetes, show the results of the VITAL-DKD trial.
Assigning student mentors to teenagers with type 1 diabetes and low socioeconomic status brings a variety of benefits to both mentors and mentees, show the results of a US pilot study.
Routine echocardiographic measures of myocardial dysfunction improve on the ability of clinical risk factors to predict major adverse cardiovascular events in people with type 1 diabetes, say researchers.
The reduced prostate cancer risk seen in men with diabetes may be partly explained by detection bias due to a lower biopsy rate following an elevated prostate-specific antigen test result, population-based study data show.
Upfront combination therapy with vildagliptin and metformin is more durable than metformin alone, and appears to have a legacy effect, report the VERIFY investigators.
Editorial Board member Lori Berard discusses how the ambulatory glucose profile is quietly revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners.
